MICHELE RUSSELL-EINHORN will join Schulman IRB as vice president for oncology services, effective Sept. 1. Russell-Einhorn will build and lead Schulman’s Central Oncology Review division, to be launched later this year. As senior director of Dana-Farber Cancer Institute’s Office for Human Research Studies, Russell-Einhorn managed and oversaw five scientific review committees and seven institutional review...
When President Donald Trump on Feb. 3 signed H.R.7148, a package funding most of the federal government through FY26, many in oncology released a long-held sigh of relief.
